Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Meryl Roudaut"'
Autor:
Meryl Roudaut, Amandine Caillaud, Zied Souguir, Lise Bray, Aurore Girardeau, Antoine Rimbert, Mikaël Croyal, Gilles Lambert, Murielle Patitucci, Gaspard Delpouve, Élodie Vandenhaute, Cédric Le May, Nathalie Maubon, Bertrand Cariou, Karim Si‐Tayeb
Publikováno v:
Bioengineering & Translational Medicine, Vol 9, Iss 4, Pp n/a-n/a (2024)
Abstract The liver plays a key role in the metabolism of lipoproteins, controlling both production and catabolism. To accelerate the development of new lipid‐lowering therapies in humans, it is essential to have a relevant in vitro study model avai
Externí odkaz:
https://doaj.org/article/53835cc8b72d4f2bb753a350085e434f
Autor:
Salam Idriss, Annik Prat, Kazem Zibara, Bertrand Cariou, Antoine Rimbert, Matthieu Pichelin, Amandine David, Meryl Roudaut, L. Arnaud, Amandine Caillaud, Xavier Prieur, Cédric Le May, Benoite Champon, Antoine Lévêque, Nabil G. Seidah, Aurore Girardeau, Karim Si-Tayeb
Publikováno v:
Stem Cell Reports
Stem Cell Reports, 2021, 16 (12), pp.2958-2972. ⟨10.1016/j.stemcr.2021.10.004⟩
Stem Cell Reports, Elsevier, 2021, ⟨10.1016/j.stemcr.2021.10.004⟩
Stem Cell Reports, 2021, ⟨10.1016/j.stemcr.2021.10.004⟩
Stem Cell Reports, 2021, 16 (12), pp.2958-2972. ⟨10.1016/j.stemcr.2021.10.004⟩
Stem Cell Reports, Elsevier, 2021, ⟨10.1016/j.stemcr.2021.10.004⟩
Stem Cell Reports, 2021, ⟨10.1016/j.stemcr.2021.10.004⟩
Summary Proprotein convertase subtilisin kexin type 9 (PCSK9) is a key regulator of low-density lipoprotein (LDL) cholesterol metabolism and the target of lipid-lowering drugs. PCSK9 is mainly expressed in hepatocytes. Here, we show that PCSK9 is hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fbd56951e30f7471ef9e5220e80f2b1
https://hal.archives-ouvertes.fr/hal-03869167
https://hal.archives-ouvertes.fr/hal-03869167
Autor:
Taha Messelmani, Anne Le Goff, Zied Souguir, Victoria Maes, Méryl Roudaut, Elodie Vandenhaute, Nathalie Maubon, Cécile Legallais, Eric Leclerc, Rachid Jellali
Publikováno v:
Bioengineering, Vol 9, Iss 9, p 443 (2022)
The 3Rs guidelines recommend replacing animal testing with alternative models. One of the solutions proposed is organ-on-chip technology in which liver-on-chip is one of the most promising alternatives for drug screening and toxicological assays. The
Externí odkaz:
https://doaj.org/article/75d65ec346af445cb6a911e18490ae19
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.